Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 10, 2022

Autologous GM-CSF–Secreting Breast Cancer Vaccine for Stage II–III and Metastatic Breast Cancers

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers
Breast Cancer Res Treat 2022 Apr 28;[EPub Ahead of Print], KS Anderson, TK Erick, M Chen, H Daley, M Campbell, Y Colson, M Mihm, LR Zakka, M Hopper, W Barry, EP Winer, G Dranoff, B Overmoyer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading